{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:27:10Z","timestamp":1788798430100,"version":"build-2803163510"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Birmingham Cancer Research UK Centre Development Fund","award":["DF-21\/TC\/0710"],"award-info":[{"award-number":["DF-21\/TC\/0710"]}]},{"name":"Birmingham Cancer Research UK Centre Development Fund","award":["DF-21\/TC\/0710"],"award-info":[{"award-number":["DF-21\/TC\/0710"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184841","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T17:31:27Z","timestamp":1505928687000},"page":"e0184841","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1909-7047","authenticated-orcid":true,"given":"Alexander C.","family":"Dowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Cobby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisheng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Devall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinnie","family":"During","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice P.","family":"Zeegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"ref1","article-title":"Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends","author":"S Antoni","year":"2016","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","article-title":"International variations in bladder cancer incidence and mortality","volume":"66","author":"S Chavan","year":"2014","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bju.12032","article-title":"A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years","volume":"112","author":"RT Bryan","year":"2013","journal-title":"BJU Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"BW van Rhijn","year":"2009","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00005650-199508000-00007","article-title":"Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis","volume":"33","author":"GF Riley","year":"1995","journal-title":"Med Care"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","author":"CL Vale","year":"2005","journal-title":"Eur Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1464-410X.2002.02776.x","article-title":"Delay and survival in bladder cancer","volume":"89","author":"DM Wallace","year":"2002","journal-title":"BJU Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"RJ Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","volume":"71","author":"M Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ju.0000162059.64886.1c","article-title":"Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials","volume":"174","author":"RJ Sylvester","year":"2005","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment","volume":"21","author":"D Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2217\/fon.14.79","article-title":"Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Guerin","volume":"10","author":"X Liu","year":"2014","journal-title":"Future Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2015.07.010","article-title":"Predicting Response to Intravesical Bacillus Calmette-Gu\u00e9rin Immunotherapy: Are We Moving Forward?","volume":"69","author":"TCM Zuiverloon","year":"2016","journal-title":"European Urology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1442-2042.2000.00190.x","article-title":"Prognostic value of tumor-associated macrophage count in human bladder cancer","volume":"7","author":"T Hanada","year":"2000","journal-title":"Int J Urol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1073\/pnas.0611618104","article-title":"CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma","volume":"104","author":"P Sharma","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1464-410X.2010.10020.x","article-title":"FOXP3 and survival in urinary bladder cancer","volume":"108","author":"ME Winerdal","year":"2011","journal-title":"BJU Int"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"TC Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1464-410X.2009.08849.x","article-title":"The West Midlands Bladder Cancer Prognosis Programme: rationale and design","volume":"105","author":"MP Zeegers","year":"2010","journal-title":"BJU International"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/exd.12487","article-title":"Cellular sources of IL-17 in psoriasis: a paradigm shift?","volume":"23","author":"RR Keijsers","year":"2014","journal-title":"Exp Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lungcan.2009.11.013","article-title":"Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients","volume":"69","author":"X Chen","year":"2010","journal-title":"Lung Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","article-title":"IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells","volume":"184","author":"D He","year":"2010","journal-title":"The Journal of Immunology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e18219","DOI":"10.1371\/journal.pone.0018219","article-title":"The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma","volume":"6","author":"L Lin","year":"2011","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e106834","DOI":"10.1371\/journal.pone.0106834","article-title":"Intratumor IL-17-Positive Mast Cells Are the Major Source of the IL-17 That Is Predictive of Survival in Gastric Cancer Patients","volume":"9","author":"X Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/bcr2195","article-title":"IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines","volume":"10","author":"X Zhu","year":"2008","journal-title":"Breast Cancer Research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/eji.201040773","article-title":"IL-17 production by \u03b3\u03b4 T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin treatment against bladder cancer","volume":"41","author":"A Takeuchi","year":"2011","journal-title":"European Journal of Immunology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"DJ Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation","volume":"198","author":"CA Murphy","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12036","article-title":"Th17 cell development: from the cradle to the grave","volume":"252","author":"LA Z\u00fa\u00f1iga","year":"2013","journal-title":"Immunological Reviews"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12865-016-0174-8","article-title":"Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis","volume":"17","author":"Y Liu","year":"2016","journal-title":"BMC Immunology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00345-012-0974-2","article-title":"First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival","volume":"30","author":"W Otto","year":"2012","journal-title":"World J Urol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1073\/pnas.0501912102","article-title":"Mast cells enhance T cell activation: Importance of mast cell-derived TNF","volume":"102","author":"S Nakae","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.4049\/jimmunol.176.7.4102","article-title":"Mast cell-associated TNF promotes dendritic cell migration","volume":"176","author":"H Suto","year":"2006","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"19977","DOI":"10.1073\/pnas.0704620104","article-title":"Mast cells are an essential hematopoietic component for polyp development","volume":"104","author":"E Gounaris","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1038\/onc.2010.348","article-title":"Mast cells have a protumorigenic role in human thyroid cancer","volume":"29","author":"RM Melillo","year":"2010","journal-title":"Oncogene"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.13.11.1382","article-title":"Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis","volume":"13","author":"LM Coussens","year":"1999","journal-title":"Genes Dev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature05010","article-title":"Mast cells are essential intermediaries in regulatory T-cell tolerance","volume":"442","author":"LF Lu","year":"2006","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ni1503","article-title":"Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B","volume":"8","author":"MA Grimbaldeston","year":"2007","journal-title":"Nat Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","article-title":"Protumor vs Antitumor Functions of IL-17","volume":"183","author":"G Murugaiyan","year":"2009","journal-title":"The Journal of Immunology"},{"key":"ref39","article-title":"Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer","author":"F Amicarella","year":"2015","journal-title":"Gut"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12094-014-1197-3","article-title":"Interleukin-17 is a favorable prognostic marker for colorectal cancer","volume":"17","author":"Y Lin","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer","volume":"71","author":"M Tosolini","year":"2011","journal-title":"Cancer Research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"L Wang","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2005.06.135","article-title":"High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder","volume":"66","author":"RJ Sylvester","year":"2005","journal-title":"Urology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00262-013-1460-4","article-title":"Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma","volume":"62","author":"B Wang","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","article-title":"Mast cells express IL-17A in rheumatoid arthritis synovium","volume":"184","author":"AJ Hueber","year":"2010","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"T Noordenbos","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1186\/ar3466","article-title":"Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium","volume":"13","author":"J Suurmond","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"AM Lin","year":"2011","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"OJ de Boer","year":"2010","journal-title":"J Pathol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0625.2009.00878.x","article-title":"Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands","volume":"18","author":"S Mrabet-Dahbi","year":"2009","journal-title":"Exp Dermatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/138920212801619232","article-title":"Bladder cancer: a simple model becomes complex","volume":"13","author":"GB Di Pierro","year":"2012","journal-title":"Curr Genomics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.urolonc.2010.04.003","article-title":"Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium","volume":"28","author":"PJ Goebell","year":"2010","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.3HI1215-542R","article-title":"Human mast cells capture, store, and release bioactive, exogenous IL-17A","volume":"100","author":"T Noordenbos","year":"2016","journal-title":"J Leukoc Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4049\/jimmunol.1200009","article-title":"The Aryl Hydrocarbon Receptor Modulates Acute and Late Mast Cell Responses","volume":"189","author":"R Sibilano","year":"2012","journal-title":"The Journal of Immunology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0022-5347(01)64210-1","article-title":"Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression","volume":"158","author":"GN Thalmann","year":"1997","journal-title":"J Urol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)66983-2","article-title":"Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin","volume":"164","author":"GN Thalmann","year":"2000","journal-title":"J Urol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.eururo.2015.06.023","article-title":"Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Gu\u00e9rin","volume":"69","author":"AM Kamat","year":"2016","journal-title":"European Urology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:59:35Z","timestamp":1602982775000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184841"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Dieli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184841","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]}}}